ProCE Banner Activity

Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC

Slideset

Review data on the role of TROP-2–targeted antibody–drug conjugates in the treatment of metastatic NSCLC. 

Released: June 21, 2024

Expiration: June 20, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.